Wall Street Zen Upgrades OrthoPediatrics (NASDAQ:KIDS) to Hold

OrthoPediatrics (NASDAQ:KIDS) was upgraded by equities research analysts at Wall Street Zen from a “sell” rating to a “hold” rating in a research note issued to investors on Saturday.

Several other brokerages have also recently issued reports on KIDS. Needham & Company LLC increased their target price on OrthoPediatrics from $26.00 to $30.00 and gave the company a “buy” rating in a research report on Friday, February 27th. Truist Financial boosted their price target on OrthoPediatrics from $19.00 to $20.00 and gave the stock a “hold” rating in a research report on Monday, March 2nd. Weiss Ratings restated a “sell (e+)” rating on shares of OrthoPediatrics in a research note on Thursday, January 22nd. BTIG Research raised their price objective on OrthoPediatrics from $23.00 to $24.00 and gave the company a “buy” rating in a research report on Friday, February 27th. Finally, TD Cowen upgraded OrthoPediatrics to a “strong-buy” rating in a research note on Tuesday, January 27th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, one has given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $24.67.

OrthoPediatrics Price Performance

Shares of KIDS stock opened at $18.05 on Friday. OrthoPediatrics has a twelve month low of $15.28 and a twelve month high of $26.40. The company has a current ratio of 5.55, a quick ratio of 3.52 and a debt-to-equity ratio of 0.28. The stock has a fifty day simple moving average of $17.75 and a two-hundred day simple moving average of $18.12. The stock has a market capitalization of $456.30 million, a price-to-earnings ratio of -10.68 and a beta of 1.07.

OrthoPediatrics (NASDAQ:KIDS) last posted its quarterly earnings results on Thursday, February 26th. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.37) by $0.11. The business had revenue of $61.61 million during the quarter, compared to analyst estimates of $61.27 million. OrthoPediatrics had a negative net margin of 16.77% and a negative return on equity of 6.70%. On average, analysts predict that OrthoPediatrics will post -0.93 EPS for the current fiscal year.

Institutional Trading of OrthoPediatrics

Institutional investors and hedge funds have recently bought and sold shares of the business. Russell Investments Group Ltd. grew its position in OrthoPediatrics by 433.1% during the 3rd quarter. Russell Investments Group Ltd. now owns 1,402 shares of the company’s stock worth $26,000 after purchasing an additional 1,139 shares during the period. Northwestern Mutual Wealth Management Co. raised its stake in shares of OrthoPediatrics by 5,226.5% during the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 2,610 shares of the company’s stock valued at $46,000 after buying an additional 2,561 shares during the last quarter. Caption Management LLC acquired a new position in shares of OrthoPediatrics in the 3rd quarter valued at about $54,000. BNP Paribas Financial Markets boosted its stake in shares of OrthoPediatrics by 60.2% in the third quarter. BNP Paribas Financial Markets now owns 3,288 shares of the company’s stock worth $61,000 after buying an additional 1,235 shares during the last quarter. Finally, State of Wyoming boosted its stake in shares of OrthoPediatrics by 189.7% in the fourth quarter. State of Wyoming now owns 6,822 shares of the company’s stock worth $121,000 after buying an additional 4,467 shares during the last quarter. 69.05% of the stock is currently owned by institutional investors and hedge funds.

About OrthoPediatrics

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.